inVentiv Health to Present at Lehman Brothers 10th Annual Global Healthcare Conference

SOMERSET, N.J., March 12 /PRNewswire-FirstCall/ -- inVentiv Health, Inc. today announced that Eran Broshy, Chairman and Chief Executive Officer will make a presentation at the Lehman Brothers 10th Annual Global Healthcare Conference taking place at the Loews Miami Beach Hotel in Miami, Florida March 19-21, 2007.

The conference will feature senior executive presentations from nearly 200 companies in the biotechnology, healthcare facilities, managed care, healthcare distribution and technology, medical supplies and devices, specialty pharmaceuticals, U.S. pharmaceuticals, Life Science Tools, European biotechnology and European pharmaceuticals categories. Conference participants will receive unique insights and perspectives as it relates to the varied healthcare sectors represented in this exclusive forum.

inVentiv's presentation will take place on Monday, March 19 at 5:15pm at the Loews Miami Beach. An audio webcast of the presentation can be accessed by logging on to http://www.inventivhealth.com/health/newsroom/webcasts.asp.

About inVentiv Health

inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its three core business segments: inVentiv Clinical, inVentiv Communications, and inVentiv Commercial. inVentiv Health works with over 200 pharmaceutical and life sciences clients, including all of the top 20 global pharmaceutical companies. For more information, visit http://www.inventivhealth.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.

CONTACT: Investors/Corporate - John Emery, CFO of inVentiv Health, Inc.,+1-732-537-4804, investor@inventivhealth.com; or Media - Felicia Vonellainof Ventiv Health, Inc., +1-212-308-7155, fvonella@inventivhealth.com

Web site: http://www.inventivhealth.com/